Literature DB >> 33513589

3D MXene microspheres with honeycomb architecture for tumor photothermal/photodynamic/chemo combination therapy.

Yaping Guo1, Hongshui Wang1, Xin Feng1, Yunbo Zhao1, Chunyong Liang1, Lei Yang1, Mingjun Li1, Yongguang Zhang1, Wei Gao2,3,4.   

Abstract

The MXene combining high surface area, prominent biocompatibility, and wide near infrared (NIR) absorption has been recognized as one of the most promising materials for tumor therapy. The application of MXene in tumor therapy is negatively affected by the current design methods lack the control of size distribution and the great tendency to agglomerate as well as poor photodynamic therapy. To solve the above problems, we report a facile strategy to process Ti3C2 nanosheets into three-dimensional (3D) structure with honeycomb structure and anti-aggregation properties for synergistic therapy of chemotherapy, photothermal and photodynamic therapy. The 3D MXene is synthesized by spray drying, in which the MXene surface is oxidized to TiO2. The microspheres present prominent NIR light trigger photothermal effect and excellent NIR light photostability, which respond in an on-off manner. Moreover, the microspheres exhibit outstanding drug-loading capability of doxorubicin (DOX) as high as 87.3%, and substantial singlet oxygen generation (1O2) was shown under 808 nm laser and UV light irradiation. Our studies indicate that 3D MXene-DOX could effectively achieve Hela cells killing in vitro, which provides a multifunctional drug delivery platform as a prospective candidate for future combined cancer therapy.

Entities:  

Year:  2021        PMID: 33513589     DOI: 10.1088/1361-6528/abe153

Source DB:  PubMed          Journal:  Nanotechnology        ISSN: 0957-4484            Impact factor:   3.874


  2 in total

1.  MXene Quantum Dot/Zeolitic Imidazolate Framework Nanocarriers for Dual Stimulus Triggered Tumor Chemo-Phototherapy.

Authors:  Xin Feng; Mingjun Li; Jianming Wang; Xianrui Zou; Hongshui Wang; Donghui Wang; Huan Zhou; Lei Yang; Wei Gao; Chunyong Liang
Journal:  Materials (Basel)       Date:  2022-06-28       Impact factor: 3.748

Review 2.  High Drug-Loading Nanomedicines for Tumor Chemo-Photo Combination Therapy: Advances and Perspectives.

Authors:  Ya Wang; Yujie Zhang; Xiaojiang Zhang; Zhe Zhang; Junjun She; Daocheng Wu; Wei Gao
Journal:  Pharmaceutics       Date:  2022-08-19       Impact factor: 6.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.